3 ms·
>The manufacturers' margins just keep climbing because they know they can raise prices without consequence. They have? According to testimony by Sanofi, even t
by gruez 5y ago
>The manufacturers' margins just keep climbing because they know they can raise prices without consequence.
They have? According to testimony by Sanofi, even though list price have went up 126%, net price has actually gone down 25%.
https://www.finance.senate.gov/imo/media/doc/26FEB2019BRANDICOURT-SANOFI.pdf https://www.finance.senate.gov/imo/media/doc/26FEB2019BRANDI...
- peytn 5y agoAh yes, “net price.” Don’t remember my accounting class covering that. What about revenue?
- gruez 5y ago>Ah yes, “net price.” Don’t remember my accounting class covering that Good thing it's covered in the report >What about revenue? Surely your accounting class tell you that rising revenue doesn't necessarily mean that "margins just keep climbing"
- sjansen 5y agoAnd most blockbusters movies never turn a profit. Color me skeptical. There’s probably similar accounting tricks at play.
- gruez 5y ago>And most blockbusters movies never turn a profit net price =/= profit. The report also covers what exactly goes into the difference between gross and net price. If you can point out what the accounting tricks are, that'll be great.
- Spooky23 5y agoIf you look at the chart in the link, about 45% of the difference between “list price” and “net price” is discounts or rebates to insurers. It’s particularly gross and brazen, even by pharmaceutical rent-seeking standards, to justify cocaine-like profit margins because large buyers can negotiate. Insulin prices are driven by anticompetitive behavior. If you look at metformin, a generic drug treating the same disease, profit margins are tight, driven by competitive economics. A 90-day supply is < $10 retail.